Michael Wagner, M.D.
Michael Wagner, M.D.
Assistant Professor
Clinical Research Division, Fred Hutch
Dr. Michael Wagner is a medical oncologist who specializes in treating patients with sarcoma. He studies the molecular drivers of bone and soft tissue sarcomas and leads clinical trials of immunotherapy treatments, including checkpoint inhibitors, for patients with this rare group of diseases.
Other Appointments & Affiliations
Assistant Professor
University of Washington School of Medicine
Education
B.S., Duke University
M.D., Harvard University
Residency, Internal Medicine, Mount Sinai Medical Center
Fellowship, Medical Oncology, MD Anderson Cancer Center
Research Interests
To understand the molecular drivers of sarcomas and to translate this knowledge to develop clinical trials, ultimately leading to new treatments for this rare group of diseases
Active Clinical Trials
Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant Neoplasms
Study Number: CITN-12B
Phase: I
A Pilot Study of Oraxol in Subjects With Cutaneous Angiosarcoma
Study Number: 20182222
Phase: Pilot
For the Media
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210